Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
32
|
pubmed:dateCreated |
1997-9-5
|
pubmed:abstractText |
The TRAF3 molecule interacts with the cytoplasmic carboxyl terminus (COOH terminus) of the Epstein-Barr virus-encoded oncogene LMP-1. NF-kappaB activation is a downstream signaling event of tumor necrosis factor receptor-associated factor (TRAF) molecules in other signaling systems (CD40 for example) and is an event caused by LMP-1 expression. One region capable of TRAF3 interaction in LMP-1 is the membrane-proximal 45 amino acids (188-242) of the COOH terminus. We show that this region contains the only site for binding of TRAF3 in the 200-amino acid COOH terminus of LMP-1. The site also binds TRAF2 and TRAF5, but not TRAF6. TRAF3 binds to critical residues localized between amino acids 196 and 212 (HHDDSLPHPQQATDDSG), including the PXQX(T/S) motif, that share limited identity to the CD40 receptor TRAF binding site (TAAPVQETL). Mutation of critical residues in the TRAF3 binding site of LMP-1 that prevents binding of TRAF2, TRAF3, and TRAF5 does not affect NF-kappaB-activating potential. Deletion mapping localized the major NF-kappaB activating region of LMP-1 to critical residues in the distal 4 amino acids of the COOH terminus (383-386). Therefore, TRAF3 binding and NF-kappaB activation occur through two separate motifs at opposite ends of the LMP-1 COOH-terminal sequence.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/EBV-associated membrane antigen...,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/TNF Receptor-Associated Factor 3,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Matrix Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
272
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19777-84
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9242637-Amino Acid Sequence,
pubmed-meshheading:9242637-Antigens, Viral,
pubmed-meshheading:9242637-Binding Sites,
pubmed-meshheading:9242637-Capsid,
pubmed-meshheading:9242637-Herpesvirus 4, Human,
pubmed-meshheading:9242637-Humans,
pubmed-meshheading:9242637-Molecular Sequence Data,
pubmed-meshheading:9242637-Mutagenesis, Site-Directed,
pubmed-meshheading:9242637-NF-kappa B,
pubmed-meshheading:9242637-Oncogene Proteins, Viral,
pubmed-meshheading:9242637-Proteins,
pubmed-meshheading:9242637-TNF Receptor-Associated Factor 3,
pubmed-meshheading:9242637-Tumor Cells, Cultured,
pubmed-meshheading:9242637-Viral Matrix Proteins,
pubmed-meshheading:9242637-Zinc Fingers
|
pubmed:year |
1997
|
pubmed:articleTitle |
Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs.
|
pubmed:affiliation |
Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|